Intestinal Lipase Inhibitor [EPC] - N0000175591

Name: Table of NDC products with intestinal lipase inhibitor
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000175591
Pharmacologic Name	Intestinal Lipase Inhibitor
Pharmacologic Uses	intestinal lipase inhibitor
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Intestinal Lipase Inhibitor

The table contains 3 products whose active ingredient are classified under the same pharmacologic class Intestinal Lipase Inhibitor [EPC].

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
0135-0461	Alli	Non-Proprietary Name: Orlistat	Capsule	Oral	Glaxosmithkline Consumer Healthcare Holdings (us) Llc	ACTIVE
61269-460	Xenical	Non-Proprietary Name: Orlistat	Capsule	Oral	H2-pharma Llc	ACTIVE
61269-565	Orlistat	Non-Proprietary Name: Orlistat	Capsule	Oral	H2-pharma Llc	ACTIVE